DE3889945D1 - Methoden und Materialien für die HIV-Erkennung und Therapie. - Google Patents

Methoden und Materialien für die HIV-Erkennung und Therapie.

Info

Publication number
DE3889945D1
DE3889945D1 DE3889945T DE3889945T DE3889945D1 DE 3889945 D1 DE3889945 D1 DE 3889945D1 DE 3889945 T DE3889945 T DE 3889945T DE 3889945 T DE3889945 T DE 3889945T DE 3889945 D1 DE3889945 D1 DE 3889945D1
Authority
DE
Germany
Prior art keywords
antibodies
hiv
monoclonal
reactive
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3889945T
Other languages
English (en)
Other versions
DE3889945T2 (de
Inventor
Tsuneya Ohno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissin Food Products Co Ltd
Original Assignee
Nissin Food Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissin Food Products Co Ltd filed Critical Nissin Food Products Co Ltd
Application granted granted Critical
Publication of DE3889945D1 publication Critical patent/DE3889945D1/de
Publication of DE3889945T2 publication Critical patent/DE3889945T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-CD4 Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE3889945T 1987-02-19 1988-02-18 Methoden und Materialien für die HIV-Erkennung und Therapie. Expired - Fee Related DE3889945T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1628287A 1987-02-19 1987-02-19
US6406687A 1987-06-29 1987-06-29
US14637188A 1988-02-03 1988-02-03

Publications (2)

Publication Number Publication Date
DE3889945D1 true DE3889945D1 (de) 1994-07-14
DE3889945T2 DE3889945T2 (de) 1995-01-19

Family

ID=27360536

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3855761T Expired - Fee Related DE3855761T2 (de) 1987-02-19 1988-02-18 Verfahren und Materialien zum Nachweis und Therapie von HIV
DE3889945T Expired - Fee Related DE3889945T2 (de) 1987-02-19 1988-02-18 Methoden und Materialien für die HIV-Erkennung und Therapie.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE3855761T Expired - Fee Related DE3855761T2 (de) 1987-02-19 1988-02-18 Verfahren und Materialien zum Nachweis und Therapie von HIV

Country Status (5)

Country Link
EP (2) EP0468601B1 (de)
JP (1) JP2583555B2 (de)
AT (2) ATE147759T1 (de)
AU (1) AU609447B2 (de)
DE (2) DE3855761T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108335T1 (de) * 1989-03-03 1994-07-15 Microgenesys Inc Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
AP237A (en) * 1990-05-29 1993-04-29 Cedars Sinai Medical Center Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
EP0590057A1 (de) * 1991-06-19 1994-04-06 Immulogic Pharmaceutical Corporation Gp-120-nachahmende peptide
JPH10506613A (ja) * 1994-07-13 1998-06-30 プロジェニクス・ファーマスーティカルス・インコーポレーテッド 試料中よりｈｉｖ−１を除去するための製造物、及び該製造物の使用方法
AU3733499A (en) * 1998-05-25 1999-12-13 Asahi Kasei Kogyo Kabushiki Kaisha Cell separation device and separation method
CN112362864B (zh) * 2021-01-12 2021-04-30 广州科方生物技术股份有限公司 一种降低免疫诊断试剂背景发光值的处理剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8423659D0 (en) * 1984-09-19 1984-10-24 Pasteur Institut Cloned dna sequences
US4652599A (en) * 1984-04-23 1987-03-24 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells
FR2580177B2 (fr) * 1985-04-15 1989-06-02 Pasteur Institut Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
DK152517B (da) * 1985-08-21 1988-03-07 Nordisk Gentofte Fremgangsmaade til paavisning af infektioes aids-virus
DK155886D0 (da) * 1986-04-04 1986-04-04 Bo Arne Hofmann Vaccine og fremgangsmaade til fremstilling af denne
AU7780687A (en) * 1986-07-23 1988-02-10 Aphton Corp. Immunogens and improved methods of making immunogens
ATE135747T1 (de) * 1986-08-21 1996-04-15 Univ Columbia Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids
NZ223980A (en) * 1987-03-23 1991-02-26 Hiver Ltd An aids-type virus vaccine comprising an antibody equivalent which recognises an epitope on a cd4 cell-marker

Also Published As

Publication number Publication date
EP0468601A1 (de) 1992-01-29
AU609447B2 (en) 1991-05-02
EP0468601B1 (de) 1997-01-15
DE3855761T2 (de) 1997-06-05
JP2583555B2 (ja) 1997-02-19
EP0280468A3 (en) 1990-09-05
JPS63294795A (ja) 1988-12-01
DE3855761D1 (de) 1997-02-27
AU1190388A (en) 1988-09-01
ATE147759T1 (de) 1997-02-15
DE3889945T2 (de) 1995-01-19
EP0280468B1 (de) 1994-06-08
ATE106945T1 (de) 1994-06-15
EP0280468A2 (de) 1988-08-31

Similar Documents

Publication Publication Date Title
ES8705975A1 (es) Un metodo de deteccion o localizacion de celulas de carcinoma humano.
FI92258B (fi) Onkostatiini-A:n käyttö diagnostisessa menetelmässä
EP0751992A4 (de) Vaskularer endothelialer wachstumsfaktor 2
ATE132197T1 (de) Monoklonale antikörper
ATE106945T1 (de) Methoden und materialien für die hiv-erkennung und therapie.
DE3854550T2 (de) HIV-Peptide und Methoden für den Nachweis von HIV.
ATE73491T1 (de) Hybridomazellen und deren monoklonale antikoerper gegen den humanen pluropotenten granulozyten- kolonie stimulierenden faktor.
DE3879085D1 (de) Snrnp-a-antigen und fragmente davon.
DE68921360D1 (de) Monoklonale Antikörper von Mäusen gegen das gp41 Protein von menschlichem Immunmangelsyndrom-Virus.
DE3889581T2 (de) Monoklonale Antikörper gegen spezifische antigene Regionen des humanen Immundefizienzvirus und Methoden zur Verwendung.
DE3854267T2 (de) HIV-spezifische monoklonale Antikörper und Hybridome zu ihrer Herstellung.
FR2563630B1 (fr) Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
ES2011679A6 (es) Procedimiento para la preparacion de polipeptidos sinteticos secuenc iales inmunologicamente activos.
ATE86261T1 (de) Tumorassoziiertes antigen.
BE899484A (fr) Nouveaux determinants antigeniques apparentes a l'adenocarcinome et anticorps qui leur sont specifiques.
IT1254570B (it) Antigeni legati alla superfice esterna di eritrociti e procedimento per la loro preparazione.
SU1540269A1 (ru) Штамм гибридных культивируемых клеток животного mus musculus, используемый для получения моноклональных антител к поверхностному гликопротеину вирусов комплекса клещевого энцефалита
IT8349430A0 (it) Metodo per la produzione di proteine antigeniche specifiche del virusdell'epatite umana a, loro utilizzazione per la produzione di preparazioni farmaceutiche e mezzi diagnostici

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee